Clinical Trial

Monitoring Salivary Gland Injury in Nasopharyngeal Carcinoma Patients After Radiotherapy Using Multi-Modal Radiomics

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 14, 2025 (before its estimated June 6, 2026 completion). Its status may not reflect the trial's current state.
Summary
This prospective observational study aims to evaluate the role of intravoxel incoherent motion (IVIM) imaging and magnetic resonance fingerprinting (MRF) techniques in monitoring salivary gland injury in nasopharyngeal carcinoma (NPC) patients undergoing radiotherapy. The study will recruit patients diagnosed with NPC who are receiving standard radiotherapy, and quantitative imaging data will be collected using IVIM and MRF techniques at multiple time points, including pre-treatment, during radiotherapy, and post-treatment. The primary objective is to analyze changes in salivary gland structure and function and to identify early imaging biomarkers indicative of radiation-induced injury. The findings are expected to provide new insights into the dynamic progression of salivary gland damage, establish predictive models for the risk of xerostomia, and guide the development of personalized therapeutic strategies to mitigate long-term complications.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-24.
Trial Details
NCT Number NCT06751381
Lead Sponsor Hainan Medical College
Conditions Nasopharyngeal Carcinoma ,Xerostomia,Radiotherapy
Enrollment 45 participants
Start Date 2025-01-20
Primary Completion 2026-06-06 (estimated)
Study Completion 2026-12-06 (estimated)
Updated on ClinicalTrials.gov 2025-01-14